(A) RT-PCR for Dhcr7 mRNA in the E11.5 to P0 cortex. β-actin mRNA was used as the loading control. (B) qRT-PCR for Dhcr7 mRNA in the E11.5 to E18.5 cortex. Data is expressed as fold change over …
Related to Figure 1A.
RT-PCR for Dhcr7 mRNA in the E11.5 to P0 cortex. β-actin mRNA was used as loading control.
Related to Figure 1C.
Western blot of Dhcr7 in total cortical lysates from E13.5 to P0. The blot was re-probed for Erk1/2 as a loading control.
Related to Figure 1. Pluripotency of SLOS patient derived human iPSC lines, 3044 and 5788 were characterized. (A) Representative images of established SLOS patient derived human iPSC lines (3044 and …
Related to Figure 1—figure supplement 1B.
RT-PCR analysis of hES cell marker genes in human iPSCs derived from SLOS patients (3044 and 5788) and healthy individual (emhf2).
Related to Figure 1—figure supplement 1D.
RT-PCR analyses and Western blot analyses of differentiation markers for the three germ layers.
(A) Chemical structures of 7-DHC-derived oxysterols. LC-MS/MS analysis of (B) cholesterol and its precursors and (C) 7-DHC and cholesterol-derived oxysterols in Dhcr7+/+ and Dhcr7-/- embryonic …
Related to Figure 2.
Related to Figure 2. SLOS patient derived hiPSCs and NPCs (3044 and 5788) along hiPSCs and NPC from healthy individual (emhf2) were cultured and used for LC-MS/MS analysis sterols and oxysterols. …
(A) Western blot for Dhcr7 in 293T cells transfected with control or individual murine Dhcr7 shRNAs. The blot was re-probed for Erk1/2 as a loading control. (B and C) Mouse cortical precursors were …
Related to Figure 3A.
Western blot for Dhcr7 in 293T cells transfected with control or individual murine Dhcr7 shRNAs. The blot was re-probed for Erk1/2 as a loading control.
Related to Figure 3N.
Western blots of DHCR7 in 293T cells transfected with human control (Con) or human-specific DHCR7 shRNA (sh3) plus human DHCR7-expressing plasmid, analyzed after 24 hr. The blot was re-probed for Erk1/2.
Related to Figure 3. Human DHCR7 cDNA expressing vectors transfected murine NPCs with either murine Dhcr7 shRNA vector or control shRNA vectors. The transfected cells were cultured for 3 days, …
(A–M) E12.5 cortical precursors were cultured for 2 days in the presence of different concentrations of 7-DHC-derived oxysterols and quantified. (A) Cell were immunostained for Ki67 (green), …
(A) E18.5 cortical sections from Dhcr7+/+ and Dhcr7-/- were immunostained for Tbr1 (red), Ctip2 (green) and counterstained with DAPI (blue). (B and C) Quantifications of the absolute thickness (B) …
Related to Figure 5J.
E15.5 cortices were isolated from Dhcr7+/+ and Dhcr7-/- embryos and analyzed by western blot for phospho-TrkB, phospho-MEK, or phospho-C/EBPβ. Blots were re-probed with antibodies for total GR, TrkB, MEK, C/EBPβ, and GAPDH as loading controls.
(A) Cortical sections from Dhcr7-/- and Dhcr7+/+ embryos labeled by Edu at different developmental stages were immunostained 18 hr later for Edu (green) and Ki67 (Magenta). (B) Quantification of …
(A) Hierarchical clustering heatmap of differentially expressed genes shows distinct expression pattern changes in transcript abundance for SLOS mutant NPCs as compared to Controls. Red color …
(A) Western blot showing increased phospho-GR in E15.5 Dhcr7-/- mouse brain relative to Dhcr7+/+. (B) Image of the docked position of DHCEO (red) and OCDO (blue) in the ligand binding pocket of GR. …
Related to Figure 8A.
Western blot showing increased phospho-GR in E15.5 Dhcr7-/- mouse brain relative to Dhcr7+/+.
Related to Figure 8C.
Human neural progenitors were treated with 3.5 μM DHCEO over the indicated time periods. Lysates were probed with phosphor-GR and phosphor-TrkB and re-probed with antibodies for total GR, total TrkB or total ERK as loading controls.
Related to Figure 8M.
hNPCs were treated or not treated with MEK/ERK inhibitors, trametinib or PD98059. Western blot of phosphor-MEK. The blots were then re-probed with antibodies for total MEK as loading controls.
Related to Figure 8O.
Western blots for TrkB or MEK1/2 in lysate of 293T cells transfected with control or TrkB shRNA or MEK shRNA vector. The blots were re-probed for glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
(A) Structures of DHCEO and OCDO. (B) All generated docking positions of DHCEO (red) and ODCO (blue) along with associated scores.
Related to Figure 8. (A, D) Another SLOS hNPC line (SLOS 5788) and mNPCs from E12.5 Dhcr7-/- and Dhcr7+/+ embryonic cortices were cultured and treated with cholesterol, vitamin E, vitamin C, vitamin …
Related to Figure 8. (A) Cholesterol levels in human neural precursors (hNPC) treated with vehicle control or different concentrations of β-cyclodextrin determined by LC-MS analysis. (B) Human and …
Retention times and MS/MS transitions for oxysterol internal standards.
Relate to Figure 2 and Figure 2-Figure Supplement 2.
Retention times and MS/MS transitions for all oxysterol standards.
Relate to Figure 2 and Figure 2—figure supplement 2.
Retention times and MS/MS transitions for sterol internal standards.
Relate to Figure 2 and Figure 2—figure supplement 2.
Retention times and MS/MS transitions for sterol standards.
Relate to Figure 2 and Figure 2—figure supplement 2.
Ingenuity Pathway Analysis (IPA) reveals “development of the central nervous system” as one of the top 10 enriched Diseases and Biological Functions related to the nervous system.
Relate to Figure 7. DEGs were further analyzed with (IPA) to identify the most enriched biological functions related to the nervous system in SLOS mutant NPCs. The table below shows the top ten enriched terms corresponding to Diseases/Bio-functions along with the p-value and overlapping number of genes in the dataset.
Excel file.
List of differentially expressed genes in SLOS hNPCs relative to Control hNPCs. Relate to Figure 7.